Working the baseline panel

Return to the case. The patient's baseline panel is drawn fasting at 8:15 AM, inside the recommended morning collection window, at the same laboratory that will perform the follow-up testing on the same immunoassay platform (electrochemiluminescence immunoassay, Roche Elecsys/cobas family, Elecsys Total P1NP and Elecsys beta-CrossLaps/serum reagents in this example). That timing and method detail is not incidental; it is what makes the baseline usable for a future comparison.

The secondary-cause screen is unremarkable. Calcium is 9.4 mg/dL, phosphate 3.6 mg/dL, creatinine 0.8 mg/dL with an eGFR of 85 mL/min/1.73m2, TSH 2.1 mIU/L, intact PTH 38 pg/mL, and total ALP 72 U/L, all within or near their reference intervals. 25(OH)D is 24 ng/mL, an input to the workup rather than a pass/fail cutoff, since this patient has an established indication (a T-score in the osteoporosis range) that puts her outside the 2024 Endocrine Society against-routine-testing recommendation. Nothing here points to a secondary cause; the bone loss is being managed as primary postmenopausal osteoporosis.

The turnover markers sit inside their reference intervals: beta-CTX 0.61 ng/mL and P1NP 52 ng/mL, both read against the postmenopausal columns of this platform's manufacturer method sheet. Reported P1NP and CTX reference intervals differ meaningfully across assay generations and manufacturers for the same analyte name; that is a direct illustration of the standardization limitation described earlier, and it is one more reason a laboratory reports its own validated interval rather than a number pulled from a textbook or a different platform's package insert.

Before either marker is trusted, the specimen itself has to pass general integrity checks: correct identification and labeling, no hemolysis or clotting, no short fill, and timely, temperature-controlled processing and separation, per CLSI PRE04 general preexamination requirements for blood specimens. CLSI PRE04 explicitly defers to the manufacturer's instructions for analyte-specific stability and storage limits, so a laboratory's rejection and stability criteria for a CTX or P1NP order are built from both documents together, not from CLSI PRE04 alone. A valid baseline is a baseline drawn at the right time, on the right platform, on an acceptable specimen, all three, not any one of them.